These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531 [TBL] [Abstract][Full Text] [Related]
4. The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. Breitenstein B; Scheuer S; Pfister H; Uhr M; Lucae S; Holsboer F; Ising M; Brückl TM CNS Spectr; 2014 Apr; 19(2):165-75. PubMed ID: 23880209 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas. Athanasoulia AP; Sievers C; Ising M; Brockhaus AC; Yassouridis A; Stalla GK; Uhr M Eur J Endocrinol; 2012 Sep; 167(3):327-35. PubMed ID: 22672924 [TBL] [Abstract][Full Text] [Related]
6. Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of levosulpiride in healthy subjects. Cho HY; Yoo HD; Lee YB Neuroscience; 2010 Aug; 169(1):378-87. PubMed ID: 20438811 [TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCC2 and their impact on drug disposition. Haufroid V Curr Drug Targets; 2011 May; 12(5):631-46. PubMed ID: 21039333 [TBL] [Abstract][Full Text] [Related]
8. The clinical impact of ABCB1 polymorphisms on the treatment of psychiatric diseases. Rosenhagen MC; Uhr M Curr Pharm Des; 2011; 17(26):2843-51. PubMed ID: 21827404 [TBL] [Abstract][Full Text] [Related]
9. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression. Ray A; Tennakoon L; Keller J; Sarginson JE; Ryan HS; Murphy GM; Lazzeroni LC; Trivedi MH; Kocsis JH; DeBattista C; Schatzberg AF Pharmacogenomics J; 2015 Aug; 15(4):332-9. PubMed ID: 25487678 [TBL] [Abstract][Full Text] [Related]
10. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Uhr M; Grauer MT; Holsboer F Biol Psychiatry; 2003 Oct; 54(8):840-6. PubMed ID: 14550684 [TBL] [Abstract][Full Text] [Related]
11. Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. Breitenstein B; Scheuer S; Brückl TM; Meyer J; Ising M; Uhr M; Holsboer F J Psychiatr Res; 2016 Feb; 73():86-95. PubMed ID: 26704739 [TBL] [Abstract][Full Text] [Related]
12. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression. Singh AB; Bousman CA; Ng CH; Byron K; Berk M Transl Psychiatry; 2012 Nov; 2(11):e198. PubMed ID: 23188198 [TBL] [Abstract][Full Text] [Related]
13. ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients. Huang X; Yu T; Li X; Cao Y; Li X; Liu B; Yang F; Li W; Zhao X; Feng G; Zhang X; Dong Z; He L; Sun X; He G Pharmacogenomics; 2013 Nov; 14(14):1723-30. PubMed ID: 24192121 [TBL] [Abstract][Full Text] [Related]
14. Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo. Lin F; Hoogendijk L; Buil L; Beijnen JH; van Tellingen O Eur J Cancer; 2013 May; 49(8):2059-64. PubMed ID: 23422148 [TBL] [Abstract][Full Text] [Related]
15. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans. Dong C; Wong ML; Licinio J Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206 [TBL] [Abstract][Full Text] [Related]
16. Donepezil, a cholinesterase inhibitor used in Alzheimer's disease therapy, is actively exported out of the brain by abcb1ab p-glycoproteins in mice. Spieler D; Namendorf C; Namendorf T; von Cube M; Uhr M J Psychiatr Res; 2020 May; 124():29-33. PubMed ID: 32114029 [TBL] [Abstract][Full Text] [Related]
17. Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients. Maleki M; Sayyah M; Kamgarpour F; Karimipoor M; Arab A; Rajabi A; Gharagozli K; Shamshiri AR; Shahsavand Ananloo E Iran Biomed J; 2010 Jul; 14(3):89-96. PubMed ID: 21079659 [TBL] [Abstract][Full Text] [Related]
18. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323 [TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in ABCC2 and ABCB1 genes and their clinical impact in physiology and drug response. Wada M Cancer Lett; 2006 Mar; 234(1):40-50. PubMed ID: 16377077 [TBL] [Abstract][Full Text] [Related]
20. ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis. Breitenstein B; Brückl TM; Ising M; Müller-Myhsok B; Holsboer F; Czamara D Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):274-83. PubMed ID: 25847751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]